262 related articles for article (PubMed ID: 15065731)
1. Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women.
Sharpe TT; Lee LM; Nakashima AK; Elam-Evans LD; Fleming PL
J Community Health; 2004 Apr; 29(2):117-27. PubMed ID: 15065731
[TBL] [Abstract][Full Text] [Related]
2. Experiences with and perceptions of, barriers to substance abuse and HIV services among African American women who use crack cocaine.
MacMaster SA
J Ethn Subst Abuse; 2005; 4(1):53-75. PubMed ID: 16870572
[TBL] [Abstract][Full Text] [Related]
3. Correlates of antiretroviral utilization among hospitalized HIV-infected crack cocaine users.
Doshi RK; Vogenthaler NS; Lewis S; Rodriguez A; Metsch L; del Rio C
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1007-14. PubMed ID: 22214200
[TBL] [Abstract][Full Text] [Related]
4. Medication compliance and satisfaction with treatment for HIV disease in a sample of African-American crack cocaine smokers.
Crisp BR; Williams M; Timpson S; Ross MW
AIDS Behav; 2004 Jun; 8(2):199-206. PubMed ID: 15187481
[TBL] [Abstract][Full Text] [Related]
5. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.
Baum MK; Rafie C; Lai S; Sales S; Page B; Campa A
J Acquir Immune Defic Syndr; 2009 Jan; 50(1):93-9. PubMed ID: 19295339
[TBL] [Abstract][Full Text] [Related]
6. Targeting HIV prevention on African American crack and injection drug users.
Feist-Price S; Logan TK; Leukefeld C; Moore CL; Ebreo A
Subst Use Misuse; 2003 Jul; 38(9):1259-84. PubMed ID: 12908811
[TBL] [Abstract][Full Text] [Related]
7. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women.
Cook JA; Burke-Miller JK; Cohen MH; Cook RL; Vlahov D; Wilson TE; Golub ET; Schwartz RM; Howard AA; Ponath C; Plankey MW; Levine AM; Grey DD
AIDS; 2008 Jul; 22(11):1355-63. PubMed ID: 18580615
[TBL] [Abstract][Full Text] [Related]
8. A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users.
Ingersoll KS; Farrell-Carnahan L; Cohen-Filipic J; Heckman CJ; Ceperich SD; Hettema J; Marzani-Nissen G
Drug Alcohol Depend; 2011 Jul; 116(1-3):177-87. PubMed ID: 21306837
[TBL] [Abstract][Full Text] [Related]
9. Associations among correlates of schedule adherence to antiretroviral therapy (ART): a path analysis of a sample of crack cocaine using sexually active African-Americans with HIV infection.
Atkinson JS; Schönnesson LN; Williams ML; Timpson SC
AIDS Care; 2008 Feb; 20(2):253-62. PubMed ID: 18293137
[TBL] [Abstract][Full Text] [Related]
10. Binge use of crack cocaine and sexual risk behaviors among African-American, HIV-positive users.
Harzke AJ; Williams ML; Bowen AM
AIDS Behav; 2009 Dec; 13(6):1106-18. PubMed ID: 18758935
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.
Hayashi K; Wood E; Kerr T; Dong H; Nguyen P; Puskas CM; Guillemi S; Montaner JS; Milloy MJ
BMC Infect Dis; 2016 Aug; 16(1):455. PubMed ID: 27568002
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers.
Wechsberg WM; Lam WK; Zule WA; Bobashev G
Am J Public Health; 2004 Jul; 94(7):1165-73. PubMed ID: 15226138
[TBL] [Abstract][Full Text] [Related]
13. Violence, homelessness, and HIV risk among crack-using African-American women.
Wechsberg WM; Lam WK; Zule W; Hall G; Middlesteadt R; Edwards J
Subst Use Misuse; 2003; 38(3-6):669-700. PubMed ID: 12747401
[TBL] [Abstract][Full Text] [Related]
14. The Health Intervention Project: HIV risk reduction among African American women drug users.
Sterk CE
Public Health Rep; 2002; 117 Suppl 1(Suppl 1):S88-95. PubMed ID: 12435832
[TBL] [Abstract][Full Text] [Related]
15. Never in care: characteristics of HIV-infected crack cocaine users in 2 US cities who have never been to outpatient HIV care.
Bell C; Metsch LR; Vogenthaler N; Cardenas G; Rodriguez A; Locascio V; Kuper T; Scharf E; Marquez A; Yohannan M; del Rio C
J Acquir Immune Defic Syndr; 2010 Aug; 54(4):376-80. PubMed ID: 20173648
[TBL] [Abstract][Full Text] [Related]
16. Perceptions of sexual risks and injection for HIV among African American women who use crack cocaine in Nashville, Tennessee.
MacMaster SA; Rasch RF; Kinzly ML; Cooper RL; Adams SM
Health Soc Work; 2009 Nov; 34(4):283-91. PubMed ID: 19927477
[TBL] [Abstract][Full Text] [Related]
17. Association between smoking, crack cocaine abuse and the discontinuation of combination antiretroviral therapy in Recife, Pernambuco, Brazil.
Batista Jd; Albuquerque Mde F; Santos ML; Miranda-Filho Dde B; Lacerda HR; Maruza M; Moura LV; Coimbra I; Ximenes RA
Rev Inst Med Trop Sao Paulo; 2014; 56(2):127-32. PubMed ID: 24626414
[TBL] [Abstract][Full Text] [Related]
18. Crack cocaine use and high-risk behaviors among sexually active black adolescents.
Fullilove MT; Golden E; Fullilove RE; Lennon R; Porterfield D; Schwarcz S; Bolan G
J Adolesc Health; 1993 Jun; 14(4):295-300. PubMed ID: 8347641
[TBL] [Abstract][Full Text] [Related]
19. Double trouble: violent and non-violent traumas among women at sexual risk of HIV infection.
Brown-Peterside P; Ren L; Chiasson MA; Koblin BA
Women Health; 2002; 36(3):51-64. PubMed ID: 12539792
[TBL] [Abstract][Full Text] [Related]
20. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis.
Laine C; Newschaffer CJ; Zhang D; Cosler L; Hauck WW; Turner BJ
Obstet Gynecol; 2000 Feb; 95(2):167-73. PubMed ID: 10674574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
